+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Chronic Kidney Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Chronic Kidney Disease: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 43 Pages
  • Global
From
Diabetic Nephropathy - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Diabetic Nephropathy - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 571 Pages
  • Global
From
Focal Segmental Glomerulosclerosis: Competitive Landscape - Product Thumbnail Image

Focal Segmental Glomerulosclerosis: Competitive Landscape

  • Report
  • August 2024
  • 76 Pages
  • Global
From
Alcoholic Hepatitis: Competitive Landscape - Product Thumbnail Image

Alcoholic Hepatitis: Competitive Landscape

  • Report
  • July 2024
  • 65 Pages
  • Global
From
From
Primary Sclerosing Cholangitis: Competitive Landscape - Product Thumbnail Image

Primary Sclerosing Cholangitis: Competitive Landscape

  • Report
  • June 2024
  • 65 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more